Cargando…

Improving Delivery of Secondary Prophylaxis for Rheumatic Heart Disease in a High‐Burden Setting: Outcome of a Stepped‐Wedge, Community, Randomized Trial

BACKGROUND: Health system strengthening is needed to improve delivery of secondary prophylaxis against rheumatic heart disease. METHODS AND RESULTS: We undertook a stepped‐wedge, randomized trial in northern Australia. Five pairs of Indigenous community clinics entered the study at 3‐month steps. St...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ralph, Anna P., de Dassel, Jessica L., Kirby, Adrienne, Read, Clancy, Mitchell, Alison G., Maguire, Graeme P., Currie, Bart J., Bailie, Ross S., Johnston, Vanessa, Carapetis, Jonathan R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064833/ https://www.ncbi.nlm.nih.gov/pubmed/30018165 http://dx.doi.org/10.1161/JAHA.118.009308

Ejemplares similares

Improving delivery of secondary prophylaxis for rheumatic heart disease in remote Indigenous communities: study protocol for a stepped-wedge randomised trial
por: Ralph, Anna P., et al.
Publicado: (2016)

Qualitative Evaluation of a Complex Intervention to Improve Rheumatic Heart Disease Secondary Prophylaxis
por: Read, Clancy, et al.
Publicado: (2018)

Adherence to secondary prophylaxis for rheumatic heart disease is underestimated by register data
por: de Dassel, Jessica Langloh, et al.
Publicado: (2017)

How Many Doses Make a Difference? An Analysis of Secondary Prevention of Rheumatic Fever and Rheumatic Heart Disease
por: de Dassel, Jessica Langloh, et al.
Publicado: (2018)

Long-Term Outcomes From Acute Rheumatic Fever and Rheumatic Heart Disease: A Data-Linkage and Survival Analysis Approach
por: He, Vincent Y.F., et al.
Publicado: (2016)

Rheumatic Heart Disease Prophylaxis in Older Patients: A Register-Based Audit of Adherence to Guidelines
por: Holland, James V, et al.
Publicado: (2018)

Therapeutics for rheumatic fever and rheumatic heart disease
por: Ralph, Anna P, et al.
Publicado: (2022)

Sharing success – understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease
por: Chamberlain-Salaun, Jennifer, et al.
Publicado: (2016)

Improvement in rheumatic fever and rheumatic heart disease management and prevention using a health centre-based continuous quality improvement approach
por: Ralph, Anna P, et al.
Publicado: (2013)

Global research priorities in rheumatic fever and rheumatic heart disease
por: Carapetis, Jonathan R, et al.
Publicado: (2011)

Rheumatic heart disease in The Gambia: clinical and valvular aspects at presentation and evolution under penicillin prophylaxis
por: Jaiteh, Lamin E. S., et al.
Publicado: (2021)

Rheumatic heart disease: infectious disease origin, chronic care approach
por: Katzenellenbogen, Judith M, et al.
Publicado: (2017)

Echocardiographic Screening for Rheumatic Heart Disease in Indigenous Australian Children: A Cost–Utility Analysis
por: Roberts, Kathryn, et al.
Publicado: (2017)

The case for global investment in rheumatic heart-disease control
por: Wyber, Rosemary, et al.
Publicado: (2014)

Integration of pre-exposure prophylaxis services into public HIV care clinics in Kenya: a pragmatic stepped-wedge randomised trial
por: Irungu, Elizabeth M, et al.
Publicado: (2021)

Rheumatic Fever Follow-Up Study (RhFFUS) protocol: a cohort study investigating the significance of minor echocardiographic abnormalities in Aboriginal Australian and Torres Strait Islander children
por: Rémond, Marc Gerard Wootton, et al.
Publicado: (2012)

Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations
por: Zühlke, Liesl J., et al.
Publicado: (2017)

Secondary prophylaxis in rheumatic fever: is it time to change?
por: Taddio, Andrea, et al.
Publicado: (2015)

Comparative evaluation of the stepped wedge design efficiency
por: Baio, Gianluca, et al.
Publicado: (2013)

Group sequential designs for stepped-wedge cluster randomised trials
por: Grayling, Michael J, et al.
Publicado: (2017)

Admissible multiarm stepped‐wedge cluster randomized trial designs
por: Grayling, Michael J., et al.
Publicado: (2018)

Adherence to Secondary Prophylaxis Among Patients with Acute  Rheumatic Fever and Rheumatic Heart Disease
por: Woods, John A., et al.
Publicado: (2019)

Research priorities for the primordial prevention of acute rheumatic fever and rheumatic heart disease by modifying the social determinants of health
por: Baker, Michael G, et al.
Publicado: (2023)

Bridging gaps across levels of care in rehabilitation of patients with rheumatic and musculoskeletal diseases: Results from a stepped-wedge cluster randomized controlled trial
por: Berdal, Gunnhild, et al.
Publicado: (2023)

Evaluation of a Community-Led Program for Primordial and Primary Prevention of Rheumatic Fever in Remote Northern Australia
por: Ralph, Anna P., et al.
Publicado: (2022)

Adherence to Secondary Prophylaxis for Acute Rheumatic Fever and Rheumatic Heart Disease: A Systematic Review
por: Kevat, Priya M., et al.
Publicado: (2017)

Power and sample size calculation for stepped-wedge designs with discrete outcomes
por: Xia, Fan, et al.
Publicado: (2021)

The stepped wedge trial design: a systematic review
por: Brown, Celia A, et al.
Publicado: (2006)

How important is randomisation in a stepped wedge trial?
por: Hargreaves, James R, et al.
Publicado: (2015)

Sample size calculation for a stepped wedge trial
por: Baio, Gianluca, et al.
Publicado: (2015)

Theory of general balance applied to step wedge designs
por: Bond, Simon
Publicado: (2018)

Improving primary prevention of acute rheumatic fever in Australia: consensus primary care priorities identified through an eDelphi process
por: Wyber, Rosemary, et al.
Publicado: (2022)

Editorial: Comorbidity Burden in Rheumatic Diseases
por: Nikiphorou, Elena, et al.
Publicado: (2018)

An evaluation of secondary prophylaxis for rheumatic heart disease in rural Egypt
por: Balbaa, A, et al.
Publicado: (2015)

Concerns for efficacy of a 30-valent M-protein-based Streptococcus pyogenes vaccine in regions with high rates of rheumatic heart disease
por: Giffard, Philip M., et al.
Publicado: (2019)

The thistle study: a stepped-wedge clustered trial of an intrapartum emergencies training package in Scottish maternity units
por: Lenguerrand, Erik, et al.
Publicado: (2013)

Contemporary Incidence and Prevalence of Rheumatic Fever and Rheumatic Heart Disease in Australia Using Linked Data: The Case for Policy Change
por: Katzenellenbogen, Judith M., et al.
Publicado: (2020)

Rheumatic Heart Disease Severity, Progression and Outcomes: A Multi‐State Model
por: Cannon, Jeffrey, et al.
Publicado: (2017)

Evaluation of a structured goal planning and tailored follow-up programme in rehabilitation for patients with rheumatic diseases: protocol for a pragmatic, stepped-wedge cluster randomized trial
por: Kjeken, Ingvild, et al.
Publicado: (2014)

Stepped-wedge cluster randomised trials: where, when and why?
por: Grayling, Michael, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_f2jsm6cqi207lh6893777mj1v1